# Hidden Side Effects of GLP-1 Drugs: Ozempic Chills, Hot Flashes, and More
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) deliver weight loss results, but users report temperature regulation problems that doctors rarely discuss upfront.
Beyond the well-documented nausea and constipation, patients taking these medications experience chills, hot flashes, and unpredictable sweating. Some describe sudden temperature swings that mirror menopausal symptoms. Women on GLP-1s report hot flashes intense enough to disrupt sleep and daily routines. Others experience cold sensitivity so acute they need extra layers indoors during warm months.
The mechanism remains unclear. GLP-1 agonists work by mimicking glucagon-like peptide-1, a hormone that regulates blood sugar and appetite. These drugs slow gastric emptying and alter metabolism, which could affect the body's thermoregulation systems. The hypothalamus, which controls temperature, may respond to rapid metabolic shifts triggered by the medication.
Clinical trials document gastrointestinal side effects thoroughly. Temperature dysregulation shows up sporadically in adverse event reports but rarely appears in prescribing information or patient education materials. This gap means many people encounter these symptoms unprepared and wonder if something is wrong.
Healthcare providers should normalize these conversations before patients start GLP-1s. Asking about baseline hot flashes, night sweats, and cold tolerance helps set realistic expectations. Patients benefit from knowing these effects typically emerge within the first few weeks and may improve as the body adjusts.
For those experiencing persistent temperature problems, dose adjustments or timing changes sometimes help. Layering clothes, adjusting room temperature, and staying